Analyst: This Overlooked Drug Stock Could Double

The analyst called the stock an "emerging biopharma company"

by Lillian Currens

Published on May 13, 2019 at 11:49 AM

H.C. Wainwright just initiated coverage on the drugmaker Rockwell Medical Inc (NASDAQ:RMTI). The brokerage firm started with a "buy" rating and an $11 price target, which is more than double the stock's current levels. The analyst called Rockwell, which specializes in end-stage renal disease treatments, an "emerging biopharma company."

Despite the bull note, RMTI has succumbed to broad market pressure today, down 6.8% at $4.91 at last check. Even with today's drop, the security is still holding atop the $48 region, a long-term level of resistance. Overall, the stock is up nearly 118% this year. 

RMTI Chart May 13

Rockwell Medical has been largely overlooked, with only one "strong buy" rating to its name. The consensus 12-month target price target of $11, however, is at a 124% premium to current levels, and represents an area not touched by the stock since 2015. 

Meanwhile, the 7.23 million shares sold short represents a whopping 16.2% of the stocks available float. At RMTI's average pace of trading, it would take over a month to cover all these pessimistic positions, leaving the door open for a short squeeze.  



a schaeffer's exclusive

5 NEW STOCK PICKS

We're celebrating 38 years with this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The "Trick" Used By the World's Wealthiest
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
2 Retail Stocks at New Lows Today
Escalating U.S.-China trade tensions are creating stiff headwinds
Stocks Erase Weekly Gains After Trump Reacts to China Retailiatory Tariffs
A brief yield-curve inversion also spooked Wall Street
The "Trick" Used By the World's Wealthiest
A simple way to stop picking losers, and start cashing in like Wall Street's elite.